Lantheus Holdings, Inc.

Industry

  • Digital Health
    • Disease Management
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • In Vitro Diagnostics
    • Saliva-based Testing
  • Services
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
      • Molecular Imaging
      • MRI, NMR
      • Ultrasound

Other Names/Subsidiaries

  • Cerveau Technologies
  • Evergreen Theragnostics
  • Lantheus Medical Imaging
  • Meilleur Technologies
  • Progenics Pharmaceuticals
See more in Biomedtracker

Latest on Lantheus Holdings, Inc.

Scrip

First Quarter M&A Activity Rose On The Strength Of Three Deals

 
• By Joseph Haas

Merger-and-acquisition activity in the biopharmaceutical sector had almost nowhere to go but up in the first quarter of 2025, following a historically low quarter in terms of total potential deal valu

Scrip

ITM Plots Logistics In GEP-NETs Ahead Of Drug Filing After Phase III Success

 
• By Alaric DeArment

ITM Isotope Technologies Munich is preparing the complex logistics and manufacturing it will need for commercial launch of ITM-11 (non-carrier-added 177 Lu-edotreotide), its radiopharmaceutical candid

Scrip

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Vibha Ravi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, IMMvention Collaboration

Scrip

Deal Watch: Bausch Companies Set Hectic Pace At J.P. Morgan With Five Deals

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. B+L Bolsters Ophthalmology With Acquis